Dec 11, 2024
Category
Equity
AUM (Cr.)
0.00
Exit Load (%)
0.50
Min Inv Lumpsum
5,000
Expense Ratio
0.00
Sharpe Ratio
0.00
Beta Ratio
0.00
Fund Manager
Anandha Padmanabhan Anjen
Inception Date
Risk Level
Very High
Investment Objective
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there is no assurance that the investment objective of the scheme will be achieved. The Scheme does not guarantee/ indicate any returns.